Investigational PCSK9 Inhibitor Shows Positive Results in Phase 3 Study

By April 01, 2016

Pfizer announced topline data for the Phase 3 SPIRE-AI (AutoInjector) trial where bococizumab given as a prefilled pen met its co-primary endpoints.

Avoid Compounded Hormone Meds for Menopausal Sx - Endocrine Society

By April 01, 2016

The Endocrine Society has issued a statement advising clinicians to avoid administering compounded hormone medications to treat menopausal symptoms, female sexual dysfunction, and other hormone conditions.

More Exposure to "Sunshine Vitamin" for Mom May Lower Asthma Risk in Kids

By April 01, 2016

Expecting mothers should make sure they get enough vitamin D exposure during the second trimester to reduce the child's likelihood of developing asthma, according to new research by the University of Kansas published in the American Journal of Health Economics.

Drinking More Coffee May Lower Risk of Colorectal Cancer, Study Finds

By April 01, 2016

Coffee consumption may lower the risk of colorectal cancer, according to findings from a new study published in Cancer Epidemiology, Biomarkers & Prevention.

Has the Rate of Autism Increased in the U.S.?

By April 01, 2016

According to a new Centers for Disease Control and Prevention (CDC) report, the prevalence of autism spectrum disorder (ASD) has not largely changed from 2 years ago with a rate of 1 in 68 children (1.46%).

KetoVie Peptide Formula Launched for Children With Epilepsy

By April 01, 2016

Cambrooke Therapeutics announced the launch of KetoVie Peptide, the first ketogenic hydrolyzed whey-based (peptides) formula for patients on a ketogenic diet with milk protein sensitivities and/or impaired digestive function.

Sleep Problems in Young Adults May Suggest Future Chronic Pain

By March 31, 2016

Sleep problems in young adults may predict chronic pain and worsening pain severity over time, a new study published in PAIN has shown.

Flu Vaccinations in Pregnant Women May Protect Against Stillbirths

By March 31, 2016

Researchers from Western Australia reported that seasonal influenza vaccinations may protect against stillbirth.

Not All Migraine Meds Safe for Pregnant Women, Review Finds

By March 31, 2016

Drugs that were once considered safe for pregnant women with migraines may not be, according to researcher at Wake Forest Baptist Medical Center.

Brilinta Preferred Over Clopidogrel in Updated DAPT Guidelines

By March 31, 2016

AstraZeneca announced that Brilinta (ticagrelor) is now preferred over clopidogrel for the management of patients with acute coronary syndrome (ACS) who have received a coronary stent and in non-ST elevation acute coronary syndrome (NSTE-ACS) patients treated with medical therapy alone.

Opioid Relapse Rate Decrease Seen With Naltrexone Injection

March 31, 2016

Extended-release naltrexone is associated with a lower rate of opioid relapse than usual treatment among criminal justice offenders, according to a study published in the New England Journal of Medicine.

FDA Allows New Test to Screen Blood Donations for Zika Virus

By March 30, 2016

The Food and Drug Administration (FDA) announced the availability of an investigational test by Roche Molecular Systems to screen blood donations for Zika virus.

FDA Committee Votes in Favor of Nuplazid for Parkinson's Disease Psychosis

By March 30, 2016

Acadia announced that the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted in favor (12-2) that the benefits of Nuplazid (primavanserin) outweighed the risks for the treatment of psychosis associated with Parkinson's' disease.

ACC/AHA Issue Updated Guidelines on Dual Antiplatelet Therapy in CAD

By March 29, 2016

The American College of Cardiology (ACC) and the American Heart Association (AHA) issued updated guidelines for dual antiplatelet therapy in patients with coronary artery disease (CAD).

Clinical Tool May Help Assess Risks, Benefits of Continued DAPT

By March 29, 2016

Researchers from Beth Israel Deaconess Medical Center, Boston, developed a clinical prediction score with modest accuracy in assessing ischemic and bleeding risks with dual antiplatelet therapy following coronary stent placement. Findings from the study are published in JAMA.

FDA Not Ready to Approve Brintellix for MDD-Related Cognitive Dysfunction

By March 29, 2016

Takeda and Lundbeck announced that the FDA has issued a complete response letter for the sNDA regarding the addition of new clinical trial data to the Brintellix (vortioxetine) labeling for treating certain aspects of cognitive dysfunction in adults with major depressive disorder (MDD).

Risk of Hip Fracture Lower in Those Who Adhere to Mediterranean Diet

March 29, 2016

Adherence to a Mediterranean diet is associated with reduced risk of hip fracture, according to a study published online in JAMA Internal Medicine.

Arthritis Patients May Be More Prone to Developing Periodontitis

By March 28, 2016

Rheumatoid arthritis (RA) patients have a greater prevalence and severity of periodontitis than the non-arthritis population, according to a new study published in the Korean Journal of Internal Medicine.

Skin Infection Patients Adhere to Just Over Half of Their Antibiotic Regimen, Study Finds

By March 28, 2016

Patients with Staphylococcus aureus skin and soft tissue infections took an average of 57% of their antibiotic doses after being discharged from the hospital, a new study published in Antimicrobial Agents and Chemotherapy reported.

Increased Vaccinations, Breastfeeding Linked to Less Ear Infections in Babies

By March 28, 2016

In a recent study published in Pediatrics, researchers suggested that increased breastfeeding, vaccine administration, and lower rates of smoking may be major factors in the reduced rate of ear infections in babies.

Risks of Developing Type 2 Diabetes May be Greater for Teens With Autism

March 28, 2016

Adolescents and young adults with autism spectrum disorder (ASD) are more likely to develop type 2 diabetes mellitus (T2DM), according to a study published online in Diabetes Care.

Hemophilia A Drug Launching With Needle-Free Transfer Device

By March 28, 2016

Kedrion Biopharma announced that the Food and Drug Administration (FDA) has approved the packaging of Koate Double Viral Inactivation (DVI) Antihemophilic Factor (human) with Mix2Vial, a needle-free transfer device.

Survey Finds Most Doctors Prescribe Opioids for Longer Than CDC Advises

By March 28, 2016

When doctors in the United States prescribe opioids for their patients, 99% of them hand out prescriptions that exceed the federally recommended three-day dosage limit, new research suggests.

New Homeopathic Wipes for Insect Bites and Stings Available

By March 23, 2016

Tec Labs announced the launch of Tecnu Bites & Stings Medicated Itch and Pain Relief Wipes for treating insect bites and bee stings.

First FDA-Approved 3D Printed Drug Available for Epilepsy

March 22, 2016

Aprecia announced that Spritam (levetiracetam) tablets for oral suspension are now available as adjunctive therapy in the treatment of partial-onset seizures in patients ≥4 years old, myoclonic seizures in patients ≥12 years old, and primary generalized tonic-clonic seizures in patients ≥6 years old.

Shared Parkinson's Pathogens Highlight Possible Risk of Onset With Rosacea

March 22, 2016

Rosacea is associated with an increased risk for Parkinson's disease, according to research published online in JAMA Neurology.

AANA: ED Meds Should be Avoided Prior to Surgery

March 22, 2016

The American Association of Nurse Anesthetists (AANA) is recommending that men avoid erectile dysfunction medications before surgery.

Will the Proposed FDA Glove Ban Have an Impact on Practice?

By March 21, 2016

The FDA has proposed a ban on most powdered gloves in the United States.

Sodium Bicarb Injection Recalled Due to Particulate Presence

By March 21, 2016

Hospira announced a voluntary recall of one lot of Sodium Bicarbonate Injection 8.4%, USP, due to particulate presence within a single-dose glass fliptop vial from a confirmed complaint.

Too Many Meds, Not Enough Monitoring? A Growing Concern in Older Patients

By March 21, 2016

A new study in JAMA Internal Medicine indicated that since 2005, the risk of major drug interaction in older adults has increased in those taking multiple prescriptions and dietary supplements concurrently.